Shasqi

Shasqi is at the forefront of cancer treatment innovation, employing click chemistry to deliver targeted therapies directly to tumors. Their proprietary CAPAC™ platform enables the precise localization of a click chemistry reagent within the tumor microenvironment. This reagent then activates a systemically administered protodrug. The 'click' reaction between these two components triggers a potent, localized therapeutic effect at the tumor site, while simultaneously maintaining systemic exposure levels of the treatment below toxic thresholds. This approach aims to maximize efficacy while minimizing harmful side effects, representing a significant advancement in targeted cancer therapy.